September 1 – 5 is Women’s Health Week.
In a significant stride for women’s health in Australia, TouchBio Pharmaceuticals has introduced the nation’s first ARTG-listed at-home test for chlamydia and gonorrhoea, tailored specifically for women. This innovative self-test empowers women to take charge of their sexual health privately and conveniently
Utilising a simple vaginal swab, the test delivers results in just 15 minutes with over 99% sensitivity and accuracy, offering peace of mind and facilitating early detection of these common sexually transmitted infections. Priced at $24, it provides an accessible option for women to monitor their health without the need for clinic visits.
The availability of this at-home test is particularly timely, given the rising rates of chlamydia and gonorrhoea in Australia. Chlamydia, often asymptomatic, has seen a 26% increase over the past decade, while gonorrhoea cases have surged by 157%. Early detection through such testing is crucial in preventing long-term health complications, including infertility.
TouchBio’s initiative not only enhances accessibility but also addresses the stigma often associated with STI testing. By facilitating discreet testing at home, it encourages more women to engage in regular sexual health check-ups, fostering a proactive approach to well-being.
For those interested in this empowering health tool, the TouchBio Chlamydia & Gonorrhoea At-Home Test is available for purchase online and at select pharmacies nationwide. Embrace this opportunity to prioritise your health with confidence and convenience.
Link to our soundbite about STI self test kits.
https://www.youtube.com/watch?v=7lZc8zbHprw
